We provide proven modeling & simulation, regulatory science, and scientific value assessment software and services to help our clients reduce clinical trial burden, accelerate regulatory approval and increase patient access to medicines.
For more information, visit www.certara.com.
For more information, visit www.certara.com.
Location: France, Ile-de-France, Paris
Employees: 501-1000
Phone: +1 609-716-7900
Founded date: 2008
Investors 5
| Date | Name | Website |
| - | Arsenal Ca... | arsenalcap... |
| - | Vector Cap... | vectorcapi... |
| 06.10.2021 | Mubadala C... | mubadala.c... |
| - | EQT | eqtgroup.c... |
| - | Solstice C... | solcap.com |
Mentions in press and media 20
| Date | Title | Description |
| 15.08.2024 | Certara Launches Phoenix™ Version 8.5 Drug Development Software | RADNOR, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Phoenix™ version 8.5. Phoenix is the pharmaceutical industry's gold standard in p... |
| 10.05.2024 | Health | Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge | The FDA conditionally approved sotorasib but required Amgen to conduct a study comparing the labeled dosage of 960 mg with a dosage of 240 mg. The trial, published in November, showed that the 960-mg dose may have given patients a month mor... |
| 15.12.2023 | Certara Acquires Applied BioMath to Expand Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing | Certara, Inc. announced it has acquired Applied BioMath, an industry-leader in providing model-informed drug discovery and development support to help accelerate and de-risk therapeutic research and development (R&D). Together, Certara ... |
| 21.11.2023 | Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development | Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in... |
| 13.03.2023 | AI Coming to Certara’s D360 Scientific Informatics Software | New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses. Certara, a global leader in biosimulation, is adding deep learning capabilities to D360, a... |
| 21.12.2021 | Certara Announces FDA Renewal and Expansion of Certara's Biosimulation Software for Reviewing Regulatory Submissions | PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has renewed and expanded its licenses of Certara’s proprieta... |
| 10.11.2021 | Certara Reports Third Quarter 2021 Financial Results | PRINCETON, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the third quarter of fiscal year 2021. Highlights: Revenue was $73.9 million, compar... |
| 10.11.2021 | Certara Reports Third Quarter 2021 Financial Results - Form 8-K | Certara Reports Third Quarter 2021 Financial Results Raises full year 2021 guidance, reflecting strong revenue growth and the acquisition of Pinnacle 21 PRINCETON, N.J.-November 9, 2021-- Certara, Inc. (Nasdaq: CERT), a global leader in bio... |
| 05.08.2021 | Certara Reports Second Quarter 2021 Financial Results | PRINCETON, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the second quarter of fiscal year 2021. Highlights: Revenue was $70.1 million, repre... |
| 08.07.2021 | Certara : Announces Update of BaseCase Software, the Company's Value Communication Platform | PRINCETON, N.J., July 08, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the release of BaseCase software version 2021.06, which updates the value communication software platform to include new capabilit... |
Show more